Combined and targeted drugs delivery system for colorectal cancer treatment: Conatumumab decorated, reactive oxygen species sensitive irinotecan prodrug and quercetin co-loaded nanostructured lipid carriers

Abstract

The conatumumab decorated, ROS sensitive prodrug contained combination nano-system is a promising platform for CRC therapy.